Sent to us by a reader.
Washington Post – by Amber Philips
The dramatic 400 percent rise in the cost of EpiPens is the next big flash point in the national debate over skyrocketing prescription drug prices.
It turns out that the woman at the center of this controversy has powerful political connections. My colleague Catherine Ho reports that the head of Mylan, the drug company accused of hiking the price of the pen that treats severe allergic reactions, is also the daughter of Joe Manchin, a Democratic U.S. senator from West Virginia and the state’s former governor. Continue reading “How a senator’s daughter became CEO of the company at the center of the EpiPen controversy”
